Amelie Bauer is an experienced scientist specializing in gene therapy, currently working at Roche since January 2022. Prior to this role, Amelie held positions at Helmholtz Zentrum München from June 2017 to December 2021, serving as Deputy Biological Safety Officer as well as a Doctoral Student. Amelie contributed to research as a Guest Researcher at the University of Heidelberg in the summer of 2018, focusing on the production and purification of AAV by Cesium Chloride Gradient. Additionally, Amelie completed a Master's program at the Max Planck Institute for Biochemistry from May 2016 to April 2017. Amelie earned a Doctor's Degree in Virology from Ludwig-Maximilians-Universität München (2017-2020), a Master of Science in Biology from the University of Regensburg (2014-2017), and a Bachelor of Science in Biology from the same university (2011-2014).
This person is not in the org chart
This person is not in any teams
This person is not in any offices